Study finds decline in HIV deaths for most men, women by race/ethnicity, education

October 8, 2012

Overall death rates due to human immunodeficiency virus (HIV) infection declined over time between 1993 and 2007 for most men and women by race/ethnicity and educational levels, with the largest absolute decreases for nonwhites, but rates remain high among blacks, according to a report published Online First by Archives of Internal Medicine.

Widespread use of highly (HAART) has resulted in steep declines in HIV-related mortality, but not all groups have benefited equally from its availability. Many factors influence racial and in HIV mortality rates, including differentials in the prevalence of , delays in diagnosis and an extended period before the initiation of HAART treatment, according to the study background.

Edgar P. Simard, Ph.D., M.P.H., of the , and colleagues examined trends in HIV mortality by individual levels of educational attainment as a proxy for socioeconomic status (SES) and by sex and race/ethnicity. The authors' analysis included 91,307 deaths due to HIV from 1993-2007 among individuals 25 to 64 years of age in 26 states reported to the National Vital Statistics System.

"In this large population-based analysis of trends in HIV death rates, we document overall significant, yet different, absolute and relative declines in mortality by sex, race/ethnicity and individual-level educational attainment as a proxy for SES. There were strong declines for all groups except for non-Hispanic black women of low SES," the authors note. "Relative declines were generally greater for those with higher and for non-Hispanic whites, and these trends resulted in widening gaps between these groups."

Among men with the most education, per 100,000 population decreased from 117.89 to 15.35 in blacks vs. from 26.42 to 1.79 in whites. Rates were unchanged for the least-educated black women (26.76 during 2005-2007) and remained high for similarly educated black men (52.71), the study results show.

"Notably, HIV death rates among non-Hispanic black men with 12 or fewer years of education (52.71 per 100,000 population in 2005-2007) were higher than rates among similarly educated non-Hispanic white men before widely available HIV therapies (25.77 per 100,000 population in 1993-1995)," the authors note.

Among men, the disparity rate ratio (comparing the least and the most educated) increased from 1.04 during 1993-1995 to 3.43 during 2005-2007 for blacks and from 0.98 to 2.82 for whites, according to the results.

"We documented substantial absolute declines in HIV death rates during 1993-2007 for all groups, although relative declines were greatest among those with the highest vs. lowest levels of SES, leading to widening inequalities. Notably, HIV remained markedly high among non-Hispanic black men of all SES levels and were unchanged for non-Hispanic black women in the lowest SES strata," the authors conclude. "These findings suggest the need for focused interventions and resources to facilitate the identification of high-risk individuals, as well as entry and retention into care for these most vulnerable groups affected by the HIV epidemic in the United States."

In an invited commentary, William Cunningham, M.D., M.P.H., of the University of California, Los Angeles, writes: "Currently, there is great excitement and hope in the (HIV) prevention, care and research communities regarding the conceivable end of AIDS, although not the end of HIV."

"However, there is a strong countercurrent to the enthusiasm for the prospects of a person living with HIV in the United States. That is because disparities among people of color have been observed for more than a decade during the era of highly active [antiretroviral therapy] (ART) (HAART)," Cunningham continues.

"The article by Simard et al adds solid evidence based on individual-level data in the United States showing that between the period 1993 to 1995 (before HAART) and the period 2005 to 2007 (after HAART), mortality decreased for most and women by race/ethnicity and educational levels. Also, the greatest absolute decreases were for African Americans and Latinos owing to higher baseline rates. However, of most importance for this discussion, among African Americans in the least educated group (i.e., the lowest SES group), mortality remained the highest. As the authors note, more must be done to eliminate continuing racial/ethnic and SES disparities in HIV mortality in the United States," Cunningham concludes.

Explore further: Declines in melanoma deaths limited to the most educated

More information:
Arch Intern Med. Published online October 8, 2012. doi:10.1001/archinternmed.2012.4508
Arch Intern Med. Published online October 8, 2012. doi:10.1001/2013.jamainternmed.613

Related Stories

Declines in melanoma deaths limited to the most educated

January 16, 2012
A new study from the American Cancer Society finds recent declines in melanoma mortality rates in non-Hispanic Whites in the U.S. mainly reflect declines in those with the highest level of education, and reveals a widening ...

Mortality rates for pharynx and mouth cancers have decreased

November 21, 2011
Death rates have declined among U.S. patients with cancer of the mouth and pharynx from 1993 to 2007, with the greatest decreases seen among men and women with at least 12 years of education, according to a report in the ...

Increased mortality in HIV-positive South African men versus women is unrelated to HIV/AIDS

September 4, 2012
In South Africa, HIV-infected men who are receiving treatment with anti-HIV drugs (antiretroviral therapy) are almost a third more likely to die than HIV-positive women who are receiving similar treatment: however, these ...

HIV racial disparities noted for men who have sex with men

July 20, 2012
(HealthDay) -- Similar racial disparities are seen in HIV infection for men who have sex with men (MSM) in the United States and the United Kingdom, according to a study published online July 20 in The Lancet.

Recommended for you

Scientists find where HIV 'hides' to evade detection by the immune system

October 19, 2017
In a decades-long game of hide and seek, scientists from Sydney's Westmead Institute for Medical Research have confirmed for the very first time the specific immune memory T-cells where infectious HIV 'hides' in the human ...

National roll-out of PrEP HIV prevention drug would be cost-effective

October 18, 2017
Providing pre-exposure prophylaxis (PrEP) medication to men who have sex with men who are at high risk of HIV infection (equivalent to less than 5% of men who have sex with men at any point in time) in England would be cost-effective, ...

Regulatory T cells harbor HIV/SIV virus during antiviral drug treatment

October 17, 2017
Scientists at Yerkes National Primate Research Center, Emory University have identified an additional part of the HIV reservoir, immune cells that survive and harbor the virus despite long-term treatment with antiviral drugs.

New research opens the door to 'functional cure' for HIV

October 17, 2017
In findings that open the door to a completely different approach to curing HIV infections, scientists from the Florida campus of The Scripps Research Institute (TSRI) have for the first time shown that a novel compound effectively ...

Researchers create molecule that could 'kick and kill' HIV

October 5, 2017
Current anti-AIDS drugs are highly effective at making HIV undetectable and allowing people with the virus to live longer, healthier lives. The treatments, a class of medications called antiretroviral therapy, also greatly ...

A sixth of new HIV patients in Europe 50 or older: study

September 27, 2017
People aged 50 and older comprise a growing percentage of HIV patients in Europe, accounting for one in six new cases in 2015, researchers said Wednesday.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.